The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention
- 31 August 1995
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (7-8) , 1071-1076
- https://doi.org/10.1016/0959-8049(95)00137-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Rectal cancer in FAP patient after sulindacThe Lancet, 1994
- Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemopreventionJournal of Cellular Biochemistry, 1992
- A genetic model for colorectal tumorigenesisCell, 1990
- SULINDAC TREATMENT FOR FAMILIAL POLYPOSIS COLIThe Lancet, 1985
- Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosoureaCancer Letters, 1984
- Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancerDiseases of the Colon & Rectum, 1984
- Reduction of acetoxymethyl-methylnitrosamine-induced large bowel cancer in rats by indomethacin.The Tohoku Journal of Experimental Medicine, 1984
- The suppressive effect of piroxicam on autochthonous intestinal tumors in the ratCancer Letters, 1983
- Sulindac for polyposis of the colonJournal of Surgical Oncology, 1983
- Effect of Indomethacin on Intestinal Tumors Induced in Rats by the Acetate Derivative of DimethylnitrosamineScience, 1981